The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

Here, we take a look at who’s in at the FDA, who’s out, and what could be next for the agency’s leadership ... navigating the future of the FDA’s vaccine division at a time when HHS ...

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene ...

New FDA Leadership Team: The FDA's top leadership ... Kennedy Jr.) signals potential changes in FDA priorities and how the agency engages with biotech firms. The following article analyzes ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

The US Food and Drug Administration has named ... Warp Speed effort to rapidly develop Covid-19 vaccines and treatments. Marks resigned from the agency in March with a letter criticizing US ...

The Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID ...

US FDA Names Agency Critic Vinay Prasad as Top Vaccine Official By Dan Levine ... an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center ...

(Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership ... COVID-19 vaccines and was pushed out of the agency in ...